The peptide reclassification announcement created enormous noise in compounding pharmacy and longevity clinic markets. This episode maps what is actually happening versus what was announced, and what the gap between announcement and Federal Register entry means for businesses that repositioned based on the February announcement.
We examine the regulatory…
